Pharmaceutical Companies

Kura Oncology

Country: 🇺🇸United States

Ownership: Public

Established: 2014-01-01

Employees: 142

Market Cap: $1.5B

Website: http://www.kuraoncology.com

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute...

Kura Oncology

🇺🇸United States

Ownership: Public

Established: 2014-01-01

Employees: 142

Market Cap: $1.5B

Website: http://www.kuraoncology.com

Bicycle Therapeutics Inc.

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $1.5B

Website: -

Bicycle Therapeutics Inc.

🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $1.5B

Website: -

Harrow Health

Country: 🇺🇸United States

Ownership: -

Established: 1998-01-01

Employees: -

Market Cap: $1.5B

Website: http://www.harrow.com/

Harrow Health

🇺🇸United States

Ownership: -

Established: 1998-01-01

Employees: -

Market Cap: $1.5B

Website: http://www.harrow.com/

FAGRON

Country: 🇧🇪Belgium

Ownership: -

Established: 2007-01-01

Employees: -

Market Cap: $1.5B

Website: http://www.arseus.com/en/

FAGRON

🇧🇪Belgium

Ownership: -

Established: 2007-01-01

Employees: -

Market Cap: $1.5B

Website: http://www.arseus.com/en/

Centessa Pharmaceuticals, LLC

Country: 🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $1.5B

Website: -

Centessa Pharmaceuticals, LLC

🇺🇸United States

Ownership: -

Established: -

Employees: -

Market Cap: $1.5B

Website: -

Avadel Pharmaceuticals

Country: 🇮🇪Ireland

Ownership: Public

Established: 1990-01-01

Employees: 154

Market Cap: $1.5B

Website: http://www.avadel.com

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy. The company was founded on July 21, 1990 and is headquartered in Dublin, Ireland.